Optimum Investment Advisors’s Biogen BIIB Stock Holding History

Optimum Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$46.9K	Hold	335	–	–	0.02%	360
2025 Q2	$42.1K	Hold	335	–	–	0.02%	369
2025 Q1	$45.8K	Hold	335	–	–	0.02%	351
2024 Q4	$51.2K	Hold	335	–	–	0.02%	341
2024 Q3	$64.9K	Hold	335	–	–	0.03%	324
2024 Q2	$77.7K	Hold	335	–	–	0.03%	298
2024 Q1	$72.2K	Hold	335	–	–	0.03%	318
2023 Q4	$86.7K	Sell	335 -16	-5%	-$3.93K	0.04%	278
2023 Q3	$90.2K	Hold	351	–	–	0.05%	279
2023 Q2	$100K	Hold	351	–	–	0.05%	271
2023 Q1	$97.6K	Hold	351	–	–	0.05%	269
2022 Q4	$97.2K	Hold	351	–	–	0.05%	268
2022 Q3	$94K	Hold	351	–	–	0.05%	283
2022 Q2	$72K	Hold	351	–	–	0.04%	333
2022 Q1	$74K	Hold	351	–	–	0.03%	362
2021 Q4	$84K	Hold	351	–	–	0.03%	367
2021 Q3	$99K	Hold	351	–	–	0.04%	328
2021 Q2	$122K	Hold	351	–	–	0.04%	344
2021 Q1	$98K	Hold	351	–	–	0.03%	373
2020 Q4	$86K	Sell	351 -20	-5%	-$5.16K	0.03%	377
2020 Q3	$105K	Hold	371	–	–	0.04%	328
2020 Q2	$99K	Hold	371	–	–	0.03%	327
2020 Q1	$117K	Hold	371	–	–	0.05%	285
2019 Q4	$110K	Buy	371 +16	+5%	+$4.44K	0.03%	377
2019 Q3	$83K	Sell	355 -150	-30%	-$34.9K	0.03%	403
2019 Q2	$118K	Hold	505	–	–	0.04%	343
2019 Q1	$119K	Sell	505 -75	-13%	-$23.6K	0.04%	348
2018 Q4	$175K	Sell	580 -450	-44%	-$144K	0.06%	276
2018 Q3	$364K	Sell	1,030 -75	-7%	-$25.8K	0.1%	196
2018 Q2	$321K	Buy	1,105 +16	+1%	+$4.5K	0.09%	216
2018 Q1	$298K	Hold	1,089	–	–	0.09%	226
2017 Q4	$347K	Hold	1,089	–	–	0.11%	205
2017 Q3	$341K	Hold	1,089	–	–	0.11%	206
2017 Q2	$296K	Sell	1,089 -61	-5%	-$16.1K	0.1%	218
2017 Q1	$314K	Sell	1,150 -150	-12%	-$42.4K	0.11%	213
2016 Q4	$369K	Sell	1,300 -52	-4%	-$15.4K	0.14%	192
2016 Q3	$423K	Hold	1,352	–	–	0.16%	179
2016 Q2	$327K	Buy	1,352 +250	+23%	+$65.9K	0.13%	199
2016 Q1	$287K	Hold	1,102	–	–	0.11%	206
2015 Q4	$338K	Buy	1,102 +52	+5%	+$14.9K	0.13%	198
2015 Q3	$306K	Buy	+1,050	New	+$347K	0.12%	200
2015 Q1	$422K	Hold	1,000	–	–	0.13%	177
2014 Q4	$339K	Hold	1,000	–	–	0.11%	192
2014 Q3	$331K	Hold	1,000	–	–	0.11%	185
2014 Q2	$315K	Hold	1,000	–	–	0.1%	198
2014 Q1	$306K	Hold	1,000	–	–	0.12%	181
2013 Q4	$280K	Hold	1,000	–	–	0.11%	183
2013 Q3	$241K	Buy	+1,000	New	+$224K	0.1%	182

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Optimum Investment Advisors's BIIB Position: Q3 2025 in Review

Optimum Investment Advisors held its Biogen (BIIB) position steady in Q3 2025 at 335 shares worth $46.9K. The position accounts for 0.02% of the portfolio, ranked #360.

Optimum Investment Advisors first reported a position in BIIB in Q3 2013 and has held it in 48 quarters since. The position peaked at $423K in Q3 2016. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

Optimum Investment Advisors held 335 shares of Biogen worth $46.9K as of Q3 2025.
Optimum Investment Advisors left its Biogen share count unchanged in Q3 2025.
Biogen made up 0.02% of Optimum Investment Advisors's portfolio in Q3 2025, its #360 holding.
Optimum Investment Advisors first reported a position in Biogen in Q3 2013 and has held it in 48 quarters since.
Optimum Investment Advisors's Biogen position peaked at $423K in Q3 2016.
906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.